News - Page 2 of 4

Hemanext Announces Close of Series B Equity Funding Round

Raises $18 Million in New Equity Financing Appoints Healthcare Luminary Dr. Ismail Kola to Board of Directors, Adding Clinical Development Expertise Progresses European Commercial Launch with Rollout to Key Distributors and Leading Hospitals and Blood Centers...

European Patients Have Begun Receiving Transfusions with Hemanext ONE® RBC Processing and Storage System

Press Release, Hemanext

LEXINGTON, Mass., September 7, 2022, PR NEWSWIRE – Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced that it has initiated the rollout of its Hemanext ONE® RBC (Red Blood Cell) Processing and Storage System in...

Hemanext Announces Publication of Hypoxic Blood Storage Study in Blood Advances

Hemanext, Press Release

Research shows that hypoxic storage preserves faster oxygen unloading from red blood cells compared to standard conditions.1 PRESS RELEASE – LEXINGTON, Mass., August 5, 2022 – (PR.com) – Hemanext Inc. Hypoxic storage preserves faster oxygen unloading from red blood...

Hemanext Launches European Sales of Hemanext ONE® System in Italy and the Nordics

Hemanext, Press Release

Hemanext signs agreements with leading European healthcare distributors to provide hospitals and clinicians with Hemanext ONE® system, marking the initiation of commercialization activities after CE Mark certification LEXINGTON, Mass., August 23, 2022, PR NEWSWIRE –...

Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa

Hemanext, Press Release

LEXINGTON, Mass., July 05, 2022 – (PR.com) – Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing and storage technology, today announced the appointment of Daan Kok as the Executive Vice President & General Manager of...

Science Innovation Forum

Hemanext, Events, News

Science & Innovation Forum – The Impact of Red Blood Cell Transfusions on Biomarkers of Hemorrhagic Shock and Traumatic Brain Injury Please note: AABB reserves the right to make updates to this program. When: Thursday, May 5, 2022 4:00 – 5:00 PM (ET)...

Hemanext Announces Partnership with Aplastic Anemia & MDS International Foundation

Hemanext, AAMDS, Press Release

LEXINGTON, Mass., February 02, 2022, PR NEWSWIRE – Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing, storage, and transfusion technology, is proud to announce a new partnership with The Aplastic Anemia & MDS International...

Hemanext ONE Becomes First Blood Processing and Storage System to Receive Standards-Compliant Seal from AABB

Hemanext, HemanextInvS, Press Release

LEXINGTON, Mass., January 24, 2022, PR NEWSWIRE – Hemanext Inc. today announced that Hemanext ONE®, its innovative blood processing and storage system, has been recognized by the Association for the Advancement of Blood & Biotherapies (“AABB”), a...

Hemanext Submits Hemanext ONE System to FDA For U.S. Marketing Authorization

Hemanext, HemanextInvF, News, Press Release

Innovative Blood Processing and Storage System Received CE Mark Certification for Sale in European Markets Last Year LEXINGTON, Mass., January 5, 2022, PR NEWSWIRE – Hemanext Inc., a leading innovator in blood processing and storage technology, announced that it...

Hemanext successfully closes series a equity funding round, bringing total raised to more than $100 million

Press Release

Leading Blood Storage Innovator Expanded Series A Round to Accommodate Interest from Noted Private Investors Transformative Technology CE Marked for Sale in European Markets in April 2021; Company Will Submit for FDA Authorization Later This Year LEXINGTON, Mass.,...

« Older Entries

Next Entries »

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

YOU ARE ABOUT TO EXIT A US HEMANEXT CORPORATE WEBSITE FOR A GLOBAL HEMANEXT ONE PRODUCT WEBSITE

Recent Posts